FindTrial
Sign In

Response of chemotherapy in ca ovary observation study

Correlation of CA 125 KELIM ELIMination rate constant K and Chemotherapy response score CRS score in patients with High grade Serous Epithelial Ovarian Cancer undergoing Interval cytoreductive surgery - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/089260
Enrollment
50
Registered
2025-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

Intervention1: NIL: NIL

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women with advanced HGSEOC undergoing 3 weekly NACT cycles. 2. Age greater than 18 years 3. Willing to participate.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing primary cytoreductive surgery. 2. Previous history of treatment (chemotherapy or surgery) 3. Recurrent ovarian cancer 4. Low grade serous, clear cell, mucinous, Brenner pathological variants of EOC

Design outcomes

Primary

MeasureTime frame
1. To assess the Correlation between CA-125 based KELIM and CRS scores in women with HGSEOC undergoing interval cytoreductive surgery after neoadjuvant chemotherapy.Timepoint: 2 to 4 weeks after surgery—

Secondary

MeasureTime frame
1. Correlation of KELIM score with radiological response in HGEOC patients undergoing IDS 2. To Correlate the KELIM score with residual disease after Interval cytoreductive surgery in women with HGEOC.Timepoint: 4 weeks—

Countries

India

Contacts

Public ContactSoundharia R

AIIMS New Delhi

drseemasinghal@gmail.com9818291001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026